340
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

Osteopontin increases breast cancer cell sensitivity to specific signaling pathway inhibitors in preclinical models

Pages 680-690 | Received 19 Apr 2011, Accepted 11 Jul 2011, Published online: 15 Oct 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Pieter H. Anborgh, Danny J. Lee, Pieter F. Stam, Alan B. Tuck & Ann F. Chambers. (2018) Role of osteopontin as a predictive biomarker for anti-EGFR therapy in triple-negative breast cancer. Expert Opinion on Therapeutic Targets 22:8, pages 727-734.
Read now
Monalisa Bandopadhyay, Anuradha Bulbule, Ramesh Butti, Goutam Chakraborty, Priyanka Ghorpade, Pompom Ghosh, Mahadeo Gorain, Smita Kale, Dhiraj Kumar, Santosh Kumar, Kumar VS Totakura, Gaurab Roy, Priyanka Sharma, Dattatrya Shetti, Gowrishankar Soundararajan, Dhanashri Thorat, Deepti Tomar, Radha Nalukurthi, Remya Raja, Rosalin Mishra, Amit S Yadav & Gopal C Kundu. (2014) Osteopontin as a therapeutic target for cancer. Expert Opinion on Therapeutic Targets 18:8, pages 883-895.
Read now

Articles from other publishers (6)

Antonio Maurizi & Nadia Rucci. 2022. Bone Cancer. Bone Cancer 129 143 .
Amir Tajbakhsh, Mahdi Rivandi, Soheila Abedini, Alireza Pasdar & Amirhossein Sahebkar. (2019) Regulators and mechanisms of anoikis in triple-negative breast cancer (TNBC): A review. Critical Reviews in Oncology/Hematology 140, pages 17-27.
Crossref
Meng Wang, Jing Han, Lynnette Marcar, Josh Black, Qi Liu, Xiangyong Li, Kshithija Nagulapalli, Lecia V. Sequist, Raymond H. Mak, Cyril H. Benes, Theodore S. Hong, Kristin Gurtner, Mechthild Krause, Michael Baumann, Jing X. Kang, Johnathan R. Whetstine & Henning Willers. (2017) Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin–EGFR Pathway. Cancer Research 77:8, pages 2018-2028.
Crossref
Andrew J. Sawyer & Themis R. Kyriakides. (2016) Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization. Advanced Drug Delivery Reviews 97, pages 56-68.
Crossref
Lalita A. Shevde & Rajeev S. Samant. (2014) Role of osteopontin in the pathophysiology of cancer. Matrix Biology 37, pages 131-141.
Crossref
Ben Davidson, Yoav Smith, Jahn M. Nesland, Janne Kærn, Reuven Reich & Claes G. Tropè. (2013) Defining a prognostic marker panel for patients with ovarian serous carcinoma effusion. Human Pathology 44:11, pages 2449-2460.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.